Proposed Data Collections Submitted for Public Comment and Recommendations, 69677-69679 [2015-28475]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 217 / Tuesday, November 10, 2015 / Notices
suppliers likely to enter this market in
the near future. As there is no generic
version of Transderm Scop on the
market today, it is likely that the price
for scopolamine transdermal patches
would significantly decrease with the
onset of generic competition. Without a
remedy, the proposed acquisition would
eliminate the price reductions that
would likely have accompanied Mylan’s
independent entry into this market.
II. Entry
Entry into each of these generic
pharmaceutical markets would not be
timely, likely, or sufficient in
magnitude, character, and scope to deter
or counteract the anticompetitive effects
of the proposed acquisition. The
combination of drug development times
and regulatory requirements, including
approval by the United States Food and
Drug Administration (‘‘FDA’’), is costly
and lengthy.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
III. Effects
The proposed acquisition likely
would cause significant anticompetitive
harm to consumers by eliminating
current or future competition between
Mylan and Perrigo in these seven
concentrated markets. In each of these
markets, Mylan and Perrigo are two of
a limited number of current or likely
future suppliers in the United States.
Market participants characterize each of
the markets as a current or likely future
commodity market, in which the
number of generic suppliers has a direct
impact on pricing. Customers and
competitors have observed that the price
of generic pharmaceutical products
decreases with new entry even after
several suppliers have entered the
market. Removal of an independent
generic pharmaceutical supplier from
the relevant markets in which Mylan
and Perrigo currently compete likely
would result in significantly higher
prices post-acquisition. Similarly, the
elimination of a future independent
competitor would prevent the price
decreases that are likely to result from
the firm’s entry. Thus, absent a remedy,
the proposed acquisition will likely
cause U.S. consumers to pay
significantly higher prices for these
generic drugs.
IV. The Consent Agreement
The proposed Consent Agreement
effectively remedies the proposed
acquisition’s anticompetitive effects in
each relevant market. Under the
Consent Agreement, Mylan is required
to divest to Alvogen its rights to the
seven relevant products. Alvogen is an
international pharmaceutical company,
with commercial operations in thirty-
VerDate Sep<11>2014
19:41 Nov 09, 2015
Jkt 238001
four countries. Its business focuses on
developing, manufacturing, and
distributing generic, branded, and OTC
pharmaceutical products. Mylan must
accomplish the divestitures to Alvogen
and relinquish its rights to these
products no later than thirty days after
the proposed acquisition is
consummated.
The Commission’s goal in evaluating
possible purchasers of divested assets is
to maintain the competitive
environment that existed prior to the
proposed acquisition. If the Commission
determines that Alvogen is not an
acceptable acquirer, or that the manner
of the divestitures is not acceptable, the
proposed Order requires Mylan to
unwind the sale of rights to Alvogen
and to divest the products to a
Commission-approved acquirer within
six months of the date the Order
becomes final. The proposed Order
further allows the Commission to
appoint a trustee if Mylan fails to divest
the products as required.
The proposed Consent Agreement
contains several provisions to help
ensure that the divestitures are
successful. The Order requires Mylan to
take all action to maintain the economic
viability, marketability, and
competitiveness of the products to be
divested until such time that they are
transferred to a Commission-approved
acquirer. Mylan must provide
transitional services to Alvogen to assist
it in establishing independent
manufacturing capabilities. These
transitional services include technical
assistance to manufacture the
divestiture products in substantially the
same manner and quality employed or
achieved by Mylan, and advice and
training from knowledgeable Mylan
employees. Mylan must also provide
Alvogen with a supply of the divested
products while Mylan transfers
manufacturing technology to Alvogen or
its designated manufacturer. The goal of
the transitional services is to ensure that
Alvogen will be able to operate
independent of Mylan in the
manufacture and sale of the divested
products. Nothing in the Consent
Agreement, however, precludes Alvogen
from sourcing active pharmaceutical
ingredients or other divestiture product
inputs from Mylan on a negotiated
basis.
As Alvogen was unable to perform
due diligence on the Perrigo products at
issue, Mylan divested its own onmarket, generic acyclovir ointment
product rather than Perrigo’s product in
development. Because the competition
that is preserved by the proposed
Consent Agreement will only occur
when the Perrigo product is launched,
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
69677
the proposed Order permits Mylan to
retain the right to sell acyclovir
ointment through a license from
Alvogen until thirty days after Mylan
receives approval for the Perrigo ANDA,
but for no longer than three years. This
provision is designed to permit Mylan
to remain an active market participant
pending the approval of Perrigo’s
acyclovir ointment ANDA but also
ensures Mylan’s continued incentive to
develop and launch the Perrigo product.
The purpose of this analysis is to
facilitate public comment on the
proposed Consent Agreement, and it is
not intended to constitute an official
interpretation of the proposed Order or
to modify its terms in any way.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2015–28522 Filed 11–9–15; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–16–0943; Docket No. CDC–2015–
0098]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on Data Collection for the
Residential Care Community and Adult
Day Services Center Components of the
National Study of Long-Term Care
Providers. The purpose is to collect data
for the residential care community and
adult day services center components
for the 2016 wave of the National Study
of Long-Term Care Providers.
DATES: Written comments must be
received on or before January 11, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0098 by any of the following methods:
SUMMARY:
E:\FR\FM\10NON1.SGM
10NON1
69678
Federal Register / Vol. 80, No. 217 / Tuesday, November 10, 2015 / Notices
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
asabaliauskas on DSK5VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
care (LTC) providers; (2) merge with
existing administrative data on LTC
providers and service users (i.e., Centers
for Medicare and Medicaid Services
(CMS) data on nursing homes and
residents, home health agencies and
patients, and hospices and patients); (3)
update data more frequently on LTC
providers and service users for which
nationally representative administrative
data do not exist; and (4) enable
comparisons across LTC sectors and
timely monitoring of supply and use of
these sectors over time.
Data will be collected from two types
of LTC providers in the 50 states and the
District of Columbia: 11,690 RCCs and
5,440 ADSCs in each wave. Data were
collected in 2012 and 2014. The data to
be collected beginning in 2016 include
the basic characteristics, services,
staffing, and practices of RCCs and
ADSCs, and aggregate-level
distributions of the demographics,
selected health conditions and health
care utilization, physical functioning,
and cognitive functioning of RCC
residents and ADSC participants.
Expected users of data from this
collection effort include, but are not
limited to CDC; other Department of
Health and Human Services (DHHS)
agencies, such as the Office of the
Assistant Secretary for Planning and
Evaluation and the Agency for
Healthcare Research and Quality;
associations, such as LeadingAge
(formerly the American Association of
Homes and Services for the Aging),
National Center for Assisted Living,
American Seniors Housing Association,
Assisted Living Federation of America,
and National Adult Day Services
Association; universities; foundations;
and other private sector organizations
such as the Alzheimer’s Association and
the AARP Public Policy Institute.
Expected burden from data collection
is 30 minutes per respondent. We
estimate that 5% of RCC and ADSC
directors will be called for an additional
5 minutes of data retrieval when there
are errors or omissions in their returned
questionnaires. Two year clearance is
requested to cover the collection of data.
The burden for the collection is shown
in Table 1 below. There is no cost to
respondents other than their time to
participate.
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Residential Care Community and
Adult Day Service Center Components
of the National Study of Long-Term Care
Providers (OMB Control No. 0920–0943
Exp. Date: 07/31/2015)—Reinstatement
with change—National Center for
Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C. 242k), as
amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, ‘‘shall collect
statistics on health resources . . . [and]
utilization of health care, including
extended care facilities, and other
institutions.’’
NCHS seeks approval to collect data
for the residential care community
(RCC) and adult day services center
(ADSC) survey components of the 3rd
wave of the National Study of LongTerm Care Providers (NSLTCP). A two
year clearance is requested.
As background here are some details
on the complete study design. The
NSLTCP, a voluntary survey, is
designed to (1) broaden NCHS’ ongoing
coverage of paid, regulated long-term
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents
Type of respondents
Form name
RCC Director/Designated Staff .........
RCC Questionnaire ..........................
VerDate Sep<11>2014
19:41 Nov 09, 2015
Jkt 238001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
5,846
E:\FR\FM\10NON1.SGM
1
10NON1
Average
burden per
response
(in hrs.)
30/60
Total burden
(in hrs.)
2,923
69679
Federal Register / Vol. 80, No. 217 / Tuesday, November 10, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN TABLE—Continued
Average
burden per
response
(in hrs.)
Number of
responses per
respondent
Number of
respondents
Total burden
(in hrs.)
Type of respondents
Form name
ADSC Director/Designated Staff .......
RCC and ADSC Directors/Designated Staff.
ADSC Questionnaire ........................
Data Retrieval ..................................
2,720
429
1
1
30/60
5/60
1,360
36
Total ...........................................
...........................................................
........................
........................
........................
4,319
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–28475 Filed 11–9–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
Centers for Disease Control and
Prevention
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment for Developing a SelfManagement Tool for Individuals with
Systemic Lupus Erythematosus (SLE), to
assess the value of a tool aimed to
enhance the ability of persons with SLE
to effectively manage their condition.
DATES: Written comments must be
received on or before January 11, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0099 by any of the following methods:
Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
asabaliauskas on DSK5VPTVN1PROD with NOTICES
VerDate Sep<11>2014
19:41 Nov 09, 2015
Jkt 238001
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
FOR FURTHER INFORMATION CONTACT:
[60Day–16–16CO; Docket No. CDC–2015–
0099]
SUMMARY:
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Developing a Self-Management Tool
for Individuals with Systemic Lupus
Erythematosus (SLE)—New—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Systemic Lupus Erythematosus (SLE)
is an autoimmune disease in which the
immune system produces antibodies to
cells within the body leading to
widespread inflammation and tissue
damage. SLE has a variety of clinical
manifestations and can affect joints,
skin, the brain, lungs, kidneys, and
blood vessels. Effective SLE
management depends not only upon
clinical interventions, but also on selfmanagement—those things done on a
day-to-day basis to manage SLE. SLE
self-management requires gaining
essential knowledge, skills, and
confidence to manage the condition.
CDC previously launched a two-year
project called ‘‘Filling a Gap: Creating
E:\FR\FM\10NON1.SGM
10NON1
]]>Agencies
[Federal Register Volume 80, Number 217 (Tuesday, November 10, 2015)]
[Notices]
[Pages 69677-69679]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-28475]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-16-0943; Docket No. CDC-2015-0098]
Proposed Data Collections Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on Data Collection
for the Residential Care Community and Adult Day Services Center
Components of the National Study of Long-Term Care Providers. The
purpose is to collect data for the residential care community and adult
day services center components for the 2016 wave of the National Study
of Long-Term Care Providers.
DATES: Written comments must be received on or before January 11, 2016.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0098 by any of the following methods:
[[Page 69678]]
Federal eRulemaking Portal: Regulation.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
Residential Care Community and Adult Day Service Center Components
of the National Study of Long-Term Care Providers (OMB Control No.
0920-0943 Exp. Date: 07/31/2015)--Reinstatement with change--National
Center for Health Statistics (NCHS), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health Service (PHS) Act (42 U.S.C.
242k), as amended, authorizes that the Secretary of Health and Human
Services (DHHS), acting through NCHS, ``shall collect statistics on
health resources . . . [and] utilization of health care, including
extended care facilities, and other institutions.''
NCHS seeks approval to collect data for the residential care
community (RCC) and adult day services center (ADSC) survey components
of the 3rd wave of the National Study of Long-Term Care Providers
(NSLTCP). A two year clearance is requested.
As background here are some details on the complete study design.
The NSLTCP, a voluntary survey, is designed to (1) broaden NCHS'
ongoing coverage of paid, regulated long-term care (LTC) providers; (2)
merge with existing administrative data on LTC providers and service
users (i.e., Centers for Medicare and Medicaid Services (CMS) data on
nursing homes and residents, home health agencies and patients, and
hospices and patients); (3) update data more frequently on LTC
providers and service users for which nationally representative
administrative data do not exist; and (4) enable comparisons across LTC
sectors and timely monitoring of supply and use of these sectors over
time.
Data will be collected from two types of LTC providers in the 50
states and the District of Columbia: 11,690 RCCs and 5,440 ADSCs in
each wave. Data were collected in 2012 and 2014. The data to be
collected beginning in 2016 include the basic characteristics,
services, staffing, and practices of RCCs and ADSCs, and aggregate-
level distributions of the demographics, selected health conditions and
health care utilization, physical functioning, and cognitive
functioning of RCC residents and ADSC participants.
Expected users of data from this collection effort include, but are
not limited to CDC; other Department of Health and Human Services
(DHHS) agencies, such as the Office of the Assistant Secretary for
Planning and Evaluation and the Agency for Healthcare Research and
Quality; associations, such as LeadingAge (formerly the American
Association of Homes and Services for the Aging), National Center for
Assisted Living, American Seniors Housing Association, Assisted Living
Federation of America, and National Adult Day Services Association;
universities; foundations; and other private sector organizations such
as the Alzheimer's Association and the AARP Public Policy Institute.
Expected burden from data collection is 30 minutes per respondent.
We estimate that 5% of RCC and ADSC directors will be called for an
additional 5 minutes of data retrieval when there are errors or
omissions in their returned questionnaires. Two year clearance is
requested to cover the collection of data. The burden for the
collection is shown in Table 1 below. There is no cost to respondents
other than their time to participate.
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
RCC Director/Designated Staff. RCC 5,846 1 30/60 2,923
Questionnaire.
[[Page 69679]]
ADSC Director/Designated Staff ADSC 2,720 1 30/60 1,360
Questionnaire.
RCC and ADSC Directors/ Data Retrieval.. 429 1 5/60 36
Designated Staff.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 4,319
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-28475 Filed 11-9-15; 8:45 am]
BILLING CODE 4163-18-P
